In recent years, large-scale amino acid production projects have been launched in Hubei and other regions, marking the development of a new generation of high-demand products. Hubei and Shanghai are set to become two major domestic production hubs for amino acids, while Jilin Province is expected to establish a new production base in Northeast China. Anlitai Pharmaceutical Co., Ltd. will emerge as the largest amino acid production center in Southwest China. According to the Fine Chemicals Program of the Chinese Chemical Society, these developments signal a transformation in China's amino acid industry.
With the rapid growth of global industries such as pharmaceuticals, food, and feed, the demand for amino acids has surged. As a result, amino acids have become one of China’s key fine chemical export products. Statistics show that the output of pharmaceutical-grade amino acids in China has surpassed 4,000 tons, representing an eightfold increase since the 1980s. China has now become the world's largest producer of amino acids, exporting over 100,000 tons annually, with exports rising by 55.96% in 2006 compared to the previous year.
Despite this progress, China still faces challenges in terms of production scale, product diversity, and international competitiveness. Domestic manufacturers are generally small, with some producing only a few hundred kilograms per year. The product structure is also uneven, with many companies offering similar amino acid products. Additionally, most Chinese amino acid products lack strong international market presence. Only glutamic acid, produced by over 30 manufacturers with an annual output exceeding 1.1 million tons, holds a significant position in the global market. However, no domestic company can yet match the strength of global giants like Ajinomoto, BASF, or ADM.
Under the "Eleventh Five-Year Plan," the Chinese Chemical Society's Technical Committee has emphasized the need to develop a new generation of high-demand fine chemicals. In line with this goal, Hubei Hafeng Pharmaceutical Group is collaborating with Wuhan University, while Shanghai is partnering with leading Japanese firms to launch long-term amino acid product lines that address market shortages. A major new production base, funded by an 800 million yuan investment from Hong Kong, is being established in Northeast China. Meanwhile, Anlitai Pharmaceutical Co., Ltd., a joint venture between Germany, France, and Nanning, Guangxi, is set to become the largest pharmaceutical amino acid production base in Southwest China.
Once these new facilities are operational, China's amino acid industry is expected to achieve a significant qualitative leap during the "Eleventh Five-Year Plan" period. With improved quality and expanded capacity, China is well on its way to becoming the world's largest producer of amino acids, both in terms of quantity and global competitiveness.
Irregular Blow Molding,Injection Special Shaped Parts,Plastic Injection Special Shaped Parts,Plastic Irregular Tube
Dandong Jinggong Heat Preservation Appliance Factory , https://www.jgplastic.com